Showing results (61-70 of 689) with videos related to

Sort By:
Pageof 69
Expert Review of Anti-Infective Therapy|December 16, 2021
Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumoniaMatteo Bassetti, Monica Melchio, Daniele Roberto Giacobbe
The Journal of Antimicrobial Chemotherapy|November 24, 2016
The current treatment landscape: candidiasisMatteo Bassetti, Maddalena Peghin, Jean-Francois Timsit
Current Opinion in Infectious Diseases|September 24, 2025
Clinical trials that could change the management of severe multidrug-resistant Gram-negative infectionsMatteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe
Current Opinion in Critical Care|July 7, 2025
Role of artificial intelligence in ICU therapeutic decision-making for severe infectionsDaniele Roberto Giacobbe, Antonio Vena, Matteo Bassetti
Expert Opinion on Drug Safety|July 3, 2023
The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infectionsMatteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe
Critical Care (London, England)|January 30, 2016
Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Matteo Bassetti, Tobias Welte, Richard G Wunderink
Current Opinion in Infectious Diseases|January 24, 2019
Prosthetic joint infections: clinical management, diagnosis, and treatmentMatteo Bassetti, Nadia Castaldo, Barbara Cadeo, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 1, 2011
Invasive candidiasis in non-hematological patientsMalgorzata Mikulska, Matteo Bassetti, Sandra Ratto, et al.
Current Opinion in Infectious Diseases|January 4, 2018
The role of dalbavancin in skin and soft tissue infectionsMatteo Bassetti, Maddalena Peghin, Alessia Carnelutti, et al.
Infection and Drug Resistance|April 20, 2018
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacinElda Righi, Alessia Carnelutti, Antonio Vena, et al.
Pageof 69